Page 216 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 216
Viral Hepatitis: Hepatitis B & D - Experimental (Cont.)
YI P0563 RNAI-BASED GENE THERAPY FOR CHRONIC HEPATITIS B:
EVALUATION IN A MURINE MODEL
Thomas Michler*, Stefanie Grosse, Stefan Mockenhaupt,
Mathias Heikenwaelder, Dirk Grimm, Ulrike Protzer, Germany
YI P0564 INCREASED IL-17, TNF A SECRETION BY TFH AND THEIR
SUBTYPE (TFH17) (CD4+CXCR5+ CCR6+) CELLS HELP IN
HBV SEROCONVERSION
Ashish K. Vyas*, Shreya Sharma, Paul David, Ankit Bhardwaj,
Nirupma Trehanpati, Shiv K. Sarin, India
YI P0565 CYTOKINE PATTERNS OF PATIENTS WITH HCV/HBV CO-
INFECTION
Steffen B. Wiegand*, Anika Wranke, Jerzy Jaroszewicz, Andrej Potthoff,
Katja Deterding, Michael P. Manns, Heiner Wedemeyer,
Markus Cornberg, Germany
YI P0566 AUTOPHAGY OF CD4+T CELLS: A NEW MECHANISM
OF SELF-REGULATION IN THE PROCESS OF CHRONIC
ePOSTERS HEPATITIS B VIRUS INFECTION
Yun Liu*, Lisha Cheng, Wei Jiang, China
YI P0567 GLOBAL PATTERNS OF HBV GENOTYPE D EPIDEMIC
DISPERSAL
Evangelia Kostaki, Dimitrios Paraskevis*, Konstantinos Angelis,
Angelos Hatzakis, Greece
P0568 TGF-B SIGNALING IS ACTIVATED IN PATIENTS WITH
CHRONIC HEPATITIS B AND IS REPRESSED BY SMAD 7
OVER EXPRESSION DURING LONG TERM ANTIVIRAL
TREATMENT
Georgios Germanidis*, Nikoletta Argentou, Prodromos Hytiroglou,
Eirini Apostolou, Themistoklis Vassiliadis, Kalliopi Patsiaoura,
Paschalis Sideras, Anastasios Germenis, Matthaios Speletas, Greece
P0569 LIVER INFLAMMASOME EXPRESSION SIGNALING MAY
BE ACTIVATED IN PATIENTS WITH CHRONIC HEPATITIS
B AND REPRESSED DURING LONG TERM ANTIVIRAL
TREATMENT
Georgios Germanidis*, Adam Molyvdas, Nikolaos Lasaridis,
Themistoklis Vassiliadis, Argyro Voumvouraki, Eugenia Laspa,
Anastasios E. Germenis, Matthaios Speletas, Greece
216 The International Liver Congress™ 2015 • ILC Programme
YI P0563 RNAI-BASED GENE THERAPY FOR CHRONIC HEPATITIS B:
EVALUATION IN A MURINE MODEL
Thomas Michler*, Stefanie Grosse, Stefan Mockenhaupt,
Mathias Heikenwaelder, Dirk Grimm, Ulrike Protzer, Germany
YI P0564 INCREASED IL-17, TNF A SECRETION BY TFH AND THEIR
SUBTYPE (TFH17) (CD4+CXCR5+ CCR6+) CELLS HELP IN
HBV SEROCONVERSION
Ashish K. Vyas*, Shreya Sharma, Paul David, Ankit Bhardwaj,
Nirupma Trehanpati, Shiv K. Sarin, India
YI P0565 CYTOKINE PATTERNS OF PATIENTS WITH HCV/HBV CO-
INFECTION
Steffen B. Wiegand*, Anika Wranke, Jerzy Jaroszewicz, Andrej Potthoff,
Katja Deterding, Michael P. Manns, Heiner Wedemeyer,
Markus Cornberg, Germany
YI P0566 AUTOPHAGY OF CD4+T CELLS: A NEW MECHANISM
OF SELF-REGULATION IN THE PROCESS OF CHRONIC
ePOSTERS HEPATITIS B VIRUS INFECTION
Yun Liu*, Lisha Cheng, Wei Jiang, China
YI P0567 GLOBAL PATTERNS OF HBV GENOTYPE D EPIDEMIC
DISPERSAL
Evangelia Kostaki, Dimitrios Paraskevis*, Konstantinos Angelis,
Angelos Hatzakis, Greece
P0568 TGF-B SIGNALING IS ACTIVATED IN PATIENTS WITH
CHRONIC HEPATITIS B AND IS REPRESSED BY SMAD 7
OVER EXPRESSION DURING LONG TERM ANTIVIRAL
TREATMENT
Georgios Germanidis*, Nikoletta Argentou, Prodromos Hytiroglou,
Eirini Apostolou, Themistoklis Vassiliadis, Kalliopi Patsiaoura,
Paschalis Sideras, Anastasios Germenis, Matthaios Speletas, Greece
P0569 LIVER INFLAMMASOME EXPRESSION SIGNALING MAY
BE ACTIVATED IN PATIENTS WITH CHRONIC HEPATITIS
B AND REPRESSED DURING LONG TERM ANTIVIRAL
TREATMENT
Georgios Germanidis*, Adam Molyvdas, Nikolaos Lasaridis,
Themistoklis Vassiliadis, Argyro Voumvouraki, Eugenia Laspa,
Anastasios E. Germenis, Matthaios Speletas, Greece
216 The International Liver Congress™ 2015 • ILC Programme
